Figure 2.
Summary of the NIH OMAR-commissioned systematic review of literature for efficacy, effectiveness, toxicity, and barriers to use of hydroxyurea among adults and children with sickle cell disease (SCD). Adapted from Lanzkron et al16 and Strouse et al.17
